BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15139575)

  • 1. Childhood asthma: healthcare resource utilisation in those with and without a diagnosis of the condition.
    Frank TL; Cropper JA; Hazell ML; Frank PI; Hannaford PC
    Respir Med; 2004 May; 98(5):454-63. PubMed ID: 15139575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of telephone or surgery asthma reviews: economic analysis of a randomised controlled trial.
    Pinnock H; McKenzie L; Price D; Sheikh A
    Br J Gen Pract; 2005 Feb; 55(511):119-24. PubMed ID: 15720933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Direct cost of medical treatment to the asthmatic patient in the pediatric emergency service of a medical care tier-two hospital].
    Ceballos Martínez ZI; González Mercado E; Jiménez Grandes I; Peralta Bahena ME; Tah Arias WF
    Rev Alerg Mex; 2003; 50(2):43-7. PubMed ID: 12825487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of asthma in New South Wales.
    Mellis CM; Peat JK; Bauman AE; Woolcock AJ
    Med J Aust; 1991 Oct; 155(8):522-8. PubMed ID: 1943931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Proportion and Healthcare Utilisation of Adult Patients with Uncontrolled Severe Asthma versus Non-Severe Asthma Seen in a Southeast Asian Hospital-Based Respiratory Specialist Clinic.
    Tay TR; Wong HS; Ihsan R; Toh HP; Choo X; Tee AK
    Ann Acad Med Singap; 2017 Jun; 46(6):217-228. PubMed ID: 28733686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of CHIP coverage on children with asthma in Alabama.
    Menachemi N; Blackburn J; Sen B; Morrisey MA; Becker DJ; Caldwell C; Kilgore ML
    Clin Pediatr (Phila); 2012 Mar; 51(3):247-53. PubMed ID: 21890839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of an audit facilitator in diagnosis and treatment of childhood asthma in general practice.
    Bryce FP; Neville RG; Crombie IK; Clark RA; McKenzie P
    BMJ; 1995 Apr; 310(6983):838-42. PubMed ID: 7711623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of a general practitioner with special interests led dermatology service in primary care.
    Coast J; Noble S; Noble A; Horrocks S; Asim O; Peters TJ; Salisbury C
    BMJ; 2005 Dec; 331(7530):1444-9. PubMed ID: 16339217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden attributable to asthmatic inpatients and outpatients in a military hospital, Vietnam: A retrospective 5-year analysis.
    Vo TQ; Nguyen HM; Thai TH; La VN; Truong QK
    J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S41-S48. PubMed ID: 31369533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inpatient resource utilisation in younger (2-5 yrs) and older (6-14 yrs) asthmatic children in Finland.
    Valovirta E; Kocevar VS; Kaila M; Kajosaari M; Koivikko A; Korhonen K; Linna O; Mäkelä M; Remes K; Ben-Joseph RH
    Eur Respir J; 2002 Aug; 20(2):397-402. PubMed ID: 12212973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
    Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
    Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating asthma education and smoking cessation for parents: financial return on investment.
    McQuaid EL; Garro A; Seifer R; Hammond SK; Borrelli B
    Pediatr Pulmonol; 2012 Oct; 47(10):950-5. PubMed ID: 22467563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
    Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
    J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection.
    Greenough A; Alexander J; Burgess S; Bytham J; Chetcuti PA; Hagan J; Lenney W; Melville S; Shaw NJ; Boorman J; Coles S; Turner J; Pang F
    Arch Dis Child; 2004 Jul; 89(7):673-8. PubMed ID: 15210503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delay in diagnosis of childhood asthma and its influence on respiratory consultation rates.
    Charlton I; Jones K; Bain J
    Arch Dis Child; 1991 May; 66(5):633-5. PubMed ID: 2039256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of out of hours health services: a cross sectional survey.
    Brogan C; Pickard D; Gray A; Fairman S; Hill A
    BMJ; 1998 Feb; 316(7130):524-7. PubMed ID: 9501716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype.
    Basu A; Dalal A; Canonica GW; Forshag M; Yancey SW; Nagar S; Bell CF
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):121-131. PubMed ID: 28277854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes evaluation of a comprehensive intervention program for asthmatic children enrolled in medicaid.
    Kelly CS; Morrow AL; Shults J; Nakas N; Strope GL; Adelman RD
    Pediatrics; 2000 May; 105(5):1029-35. PubMed ID: 10790458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.